Introduction to a Special Issue of the Journal of Immunological Methods: Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies

Journal of Immunological Methods

Volumn 409, Issue , 2014, Pages 1-5

  Sanchez, Ana M ^a   Denny, Thomas N ^a   O'Gorman, Maurice ^b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

CAVD; CHAVI; EQAPOL; HVTN; IAVI; IQA

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CLINICAL LABORATORY; CLINICAL TRIAL (TOPIC); EDITORIAL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GOOD LABORATORY PRACTICE; HEALTH PROGRAM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PROCEDURES; IMMUNOPHENOTYPING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PUBLICATION; QUALITY CONTROL; SCIENTIFIC LITERATURE; STANDARDIZATION; STATISTICAL ANALYSIS; T LYMPHOCYTE; VIRUS NEUTRALIZATION;

CAVD; CHAVI; EQAPOL; HVTN; IAVI; IQA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; CONSENSUS; COOPERATIVE BEHAVIOR; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; INTERNATIONAL COOPERATION; LABORATORIES; LABORATORY PROFICIENCY TESTING; MONITORING, IMMUNOLOGIC; OBSERVER VARIATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84906086434     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.05.016     Document Type: Editorial

References (29)

1. Aziz N., Margolick J.B., Detels R., Rinaldo C.R., Phair J., Jamieson B.D., Butch A.W. Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study. Clin. Vaccine Immunol. 2013, 20:590.
2. Bainbridge J., Wilkening C.L., Rountree W., Louzao R., Wong J., Perza N., Garcia A., Denny T.N. The Immunology Quality Assessment Proficiency Testing Program for CD3+4+ and CD3+8+ Lymphocyte Subsets: A ten year review via longitudinal mixed effects modeling. J. Immunol. Methods 2014 Jun 6, 409:82.
3. Brambilla D.J., Granger S., Jennings C., Bremer J.W. Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays. J. Clin. Microbiol. 2001, 39:1121.
4. Brambilla D.J., Jennings C., Morack R., Granger S., Bremer J.W. Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA. J. Clin. Microbiol. 2004, 42:2819.
5. Britten C.M., Janetzki S., Butterfield L.H., Ferrari G., Gouttefangeas C., Huber C., Kalos M., Levitsky H.I., Maecker H.T., Melief C.J., O'Donnell-Tormey J., Odunsi K., Old L.J., Ottenhoff T.H., Ottensmeier C., Pawelec G., Roederer M., Roep B.O., Romero P., van der Burg S.H., Walter S., Hoos A., Davis M.M. T cell assays and MIATA: the essential minimum for maximum impact. Immunity 2012, 37:1.
6. DiFrancesco R., Rosenkranz S.L., Taylor C.R., Pande P.G., Siminski S.M., Jenny R.W., Morse G.D. Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories. Ther. Drug Monit. 2013, 35:631.
7. Ducar C., Smith D., Pinzon C., Stirewalt M., Cooper C., McElrath M.J., Hural J. the NIAID HIV Vaccine Trials Network. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal. J. Immunol. Methods 2014 Apr 4, 409:9.
8. Garcia Ambrosia, Keinonen Sarah, Sanchez Ana M., Ferrari Guido, Denny Thomas N., Moody M.Anthony Leukopak PBMC Sample Processing for Preparing Quality Control Material to Support Proficiency Testing Programs. J. Immunol. Methods 2014, 409:99.
9. Jaimes M.C., Maecker H.T., Yan M., Maino V.C., Hanley M.B., Greer A., Darden J.M., D'Souza M.P. Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing. J. Immunol. Methods 2011, 363:143.
10. Janetzki S., Britten C.M., MIATA Core Team The role of the reporting framework MIATA within current efforts to advance immune monitoring. J. Immunol. Methods 2014 May 9, 409:6.
11. Jennings C., Fiscus S.A., Crowe S.M., Danilovic A.D., Morack R.J., Scianna S., Cachafeiro A., Brambilla D.J., Schupbach J., Stevens W., Respess R., Varnier O.E., Corrigan G.E., Gronowitz J.S., Ussery M.A., Bremer J.W. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J. Clin. Microbiol. 2005, 43:5950.
12. Jennings C., Harty B., Granger S., Wager C., Crump J.A., Fiscus S.A., Bremer J.W. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J. Clin. Microbiol. 2012, 50:2737.
13. Lee J.A., Spidlen J., Boyce K., Cai J., Crosbie N., Dalphin M., Furlong J., Gasparetto M., Goldberg M., Goralczyk E.M., Hyun B., Jansen K., Kollmann T., Kong M., Leif R., McWeeney S., Moloshok T.D., Moore W., Nolan G., Nolan J., Nikolich-Zugich J., Parrish D., Purcell B., Qian Y., Selvaraj B., Smith C., Tchuvatkina O., Wertheimer A., Wilkinson P., Wilson C., Wood J., Zigon R., International Society for Advancement of Cytometry Data Standards Task, Force, Scheuermann R.H., Brinkman R.R. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A 2008, 73:926.
14. Lynch H.E., Sanchez A.M., D'Souza M.P., Rountree W., Denny T.N., Kalos M., Sempowski G.D. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays. J. Immunol. Methods 2014 May 4, 409:62.
15. Misra U.K., Chu C.T., Gawdi G., Pizzo S.V. Evidence for a second alpha 2-macroglobulin receptor. J. Biol. Chem. 1994, 269:12541.
16. Naarding M.A., Fernandez N., Kappes J.C., Hayes P., Ahmed T., Icyuz M., Edmonds T.G., Bergin P., Anzala O., Hanke T., Clark L., Cox J.H., Cormier E., Ochsenbauer C., Gilmour J. Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses. J. Immunol. Methods 2013 Nov 28, 409:161.
17. Olemukan R.E., Eller L.A., Ouma B.J., Etonu B., Erima S., Naluyima P., Kyabaggu D., Cox J.H., Sandberg J.K., Wabwire-Mangen F., Michael N.L., Robb M.L., de Souza M.S., Eller M.A. Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting. Clin. Vaccine Immunol. 2010, 17:910.
18. Richards A.J., Staats J., Enzor J., McKinnon K., Frelinger J., Denny T.N., Weinhold K.J., Chan C. Setting objective thresholds for rare event detection in flow cytometry. J. Immunol. Methods 2014 Apr 12, 409:54.
19. Rountree W., Vandergrift N., Bainbridge J., Sanchez A.M., Denny T.N. Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry. J. Immunol. Methods 2014 Jan 20, 409:72.
20. Sambor A., Garcia A., Berrong M., Pickeral J., Brown S., Rountree W., Sanchez A., Pollara J., Frahm N., Keinonen S., Kijak G.H., Roederer M., Levine G., D'Souza M.P., Jaimes M., Koup R., Denny T., Cox J., Ferrari G. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. J. Immunol Methods 2014 Apr 29, 409:107.
21. Sanchez A.M., Demarco C.T., Hora B., Keinonen S., Chen Y., Brinkley C., Stone M., Tobler L., Keating S., Schito M., Busch M.P., Gao F., Denny T.N. Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. J. Immunol Methods 2014 Apr 29, 409:117.
22. Sanchez A.M., Rountree W., Berrong M., Garcia A., Schuetz A., Cox J., Frahm N., Manak M., Sarzotti-Kelsoe M., D'Souza M.P., Denny T., Ferrari G. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay. J. Immunol. Methods 2014 Mar 28, 409:31.
23. Sarzotti-Kelsoe M., Bailer R.T., Turk E., Lin C.L., Bilska M., Greene K.M., Gao H., Todd C.A., Ozaki D.A., Seaman M.S., Mascola J.R., Montefiori D.C. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 2013 Dec 1, 409:131.
24. Sarzotti-Kelsoe M., Daniell X., Todd C.A., Bilska M., Martelli A., Labranche C., Perez L.G., Ochsenbauer C., Kappes J.C., Rountree W., Denny T.N., Montefiori D.C. Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells. J. Immunol. Methods 2014 Mar 6, 409:147.
25. Sarzotti-Kelsoe M., Needham L.K., Rountree W., Bainbridge J., Gray C.M., Fiscus S.A., Ferrari G., Stevens W.S., Stager S.L., Binz W., Louzao R., Long K.O., Mokgotho P., Moodley N., Mackay M., Kerkau M., McMillion T., Kirchherr J., Soderberg K.A., Haynes B.F., Denny T.N. The Center for HIV/AIDS Vaccine Immunology (CHAVI) Multi-site Quality Assurance Program for Cryopreserved Human Peripheral Blood Mononuclear Cells. J. Immunol. Methods 2014 Jun 5, 409:21.
26. Staats J., Enzor J., Sanchez A., Rountree W., Chan C., Jaimes M., Chan R., Gaur A., Denny T. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokin staining assays. J. Immunol. Methods 2014, 409:44.
27. Todd C.A., Sanchez A.M., Garcia A., Denny T.N., Sarzotti-Kelsoe M. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). J. Immunol. Methods 2013 Oct 9, 409:91.
28. van der Burg S.H., Kalos M., Gouttefangeas C., Janetzki S., Ottensmeier C., Welters M.J., Romero P., Britten C.M., Hoos A. Harmonization of immune biomarker assays for clinical studies. Sci. Transl. Med. 2011, 3:108ps44.
29. Weinberg A., Louzao R., Mussi-Pinhata M.M., Cruz M.L., Pinto J.A., Huff M.F., de Castro A.C., Sucupira M.C., Denny T.N. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin. Vaccine Immunol. 2007, 14:1242.